Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?

To: Toni Wheeler who wrote (2768)	1/23/2000 1:12:00 PM
From: Toni Wheeler	Respond to of 2836

TA appears to support the activity in HIV stock... Today's Action - HIV Breakout Alerts: ÿÿÿNew 13 Week High ÿÿÿPositive 10 Day Moving Average Breakout ÿÿÿPositive 8/17/0 Week MACD Breakout Searches: ÿÿÿTelescan's Best Search - AMEX Stocks Click on 'Dicpher': <<<During the most recent session, HIV opened at 2.562 with a daily high of 3.125 and a low of 2.562. The last trade for HIV was at 3.125 with volume of 337,600 shares traded. 323% of the stock's thirty-day average volume has been traded in the most recent session. Posting a notable gain in the most recent twenty-six and twelve week periods, HIV scores in the top half of all stocks with respect to it's long-term technical ranking. The stock shows strong long-term growth potential in its current uptrend and exhibits a positive divergence from the 200 and 50 day moving average lines. HIV is showing substantial improvements in growth potential given its recent gains in long-term technical ranking. The 200-day moving average line charts the price trend of a stock during the most recent 200-day period. HIV currently shows a negative divergence from the 200-day moving average line indicating that the stock is in a downtrend. Monitoring the relationship of a stock's price relative to the 200-day moving average line is a useful method for tracking the momentum of this stock's value. Often, the greater the divergence from the 200-day moving average line, the steeper the downtrend. With a negative divergence from the 50-day moving average line, HIV is exhibiting a downtrend. If the stock continues to slide away from the 50-day moving average line, this might signal increased momentum for its current downtrend. If losses are accompanied by heavy volume, it is a bearish signal for the stock's intermediate-term outlook indicating continued downside potential. If HIV posts gains and continues to move toward the 50-day moving average line, look for a break above this mark on strong volume as indication of a new uptrend for the stock. HIV is currently below its 10-day moving average line by a substantial margin. A strong negative divergence from this point of reference indicates that the stock may be oversold in the short-term and that a reversal may soon be in order. If the stock is above either its 50 or 200-day moving average lines, but below the 10-day line, this would be a sign of short-term weakness and signal growing buying pressure for HIV. Further, if this negative divergence occurs on heavy relative volume, then a new downtrend could be underway. If, however, HIV is significantly below all three of these moving average lines, the stock would be considered to be in a strong downtrend. Market timing requires a sophisticated understanding of a stock's relationship to its moving average lines. Considering other technical indicators in conjunction with moving average lines is also recommended. With its latest open at 2.562, HIV shows a negative opening gap of more than 5%. This price action indicates that selling pressure is increasing for the stock; however, further research is recommended to uncover precisely what news or events are driving this downside momentum for HIV. Measured by a combination of the MACD indicator, one-week relative performance and moving average ratios, HIV appears to be trending sideways. The stock has not posted any recent significant gains, and this powerful combination of technical indicators implies that HIV is consolidating for the short-term. Further investigation of the long-term technical ranking for the stock should reveal actual future prospects. Momentum is building for the stock. The above report is based on mathematical calculations and, as such, no investment decision should be based solely on its conclusions. Follow this link for the full disclaimer.>>> tscn.com My best, T.